Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
de Bruijn, Renée F.A.G.
Direk, Nese
Mirza, Saira Saeed
Hofman, Albert
Koudstaal, Peter J.
Tiemeier, Henning
and
Ikram, M. Arfan
2014.
Anxiety Is Not Associated with the Risk of Dementia or Cognitive Decline: The Rotterdam Study.
The American Journal of Geriatric Psychiatry,
Vol. 22,
Issue. 12,
p.
1382.
Pietrzak, Robert H.
Scott, J. Cobb
Neumeister, Alexander
Lim, Yen Ying
Ames, David
Ellis, Kathryn A.
Harrington, Karra
Lautenschlager, Nicola T.
Szoeke, Cassandra
Martins, Ralph N.
Masters, Colin L.
Villemagne, Victor L.
Rowe, Christopher C.
and
Maruff, Paul
2014.
Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study.
British Journal of Psychiatry,
Vol. 204,
Issue. 5,
p.
400.
Gavrilova, S. I.
Preuss, U. W.
Wong, J. W. M.
Hoerr, R.
Kaschel, R.
and
Bachinskaya, N.
2014.
Efficacy and safety of Ginkgo biloba extract EGb 761® in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo‐controlled, double‐blind, multi‐center trial.
International Journal of Geriatric Psychiatry,
Vol. 29,
Issue. 10,
p.
1087.
Tifratene, Karim
Robert, Philippe
Metelkina, Asya
Pradier, Christian
and
Dartigues, Jean François
2015.
Progression of mild cognitive impairment to dementia due to AD in clinical settings.
Neurology,
Vol. 85,
Issue. 4,
p.
331.
Mah, Linda
Binns, Malcolm A.
and
Steffens, David C.
2015.
Anxiety Symptoms in Amnestic Mild Cognitive Impairment Are Associated with Medial Temporal Atrophy and Predict Conversion to Alzheimer Disease.
The American Journal of Geriatric Psychiatry,
Vol. 23,
Issue. 5,
p.
466.
Cummings, Damian M.
Liu, Wenfei
Portelius, Erik
Bayram, Sevinç
Yasvoina, Marina
Ho, Sui-Hin
Smits, Hélène
Ali, Shabinah S.
Steinberg, Rivka
Pegasiou, Chrysia-Maria
James, Owain T.
Matarin, Mar
Richardson, Jill C.
Zetterberg, Henrik
Blennow, Kaj
Hardy, John A.
Salih, Dervis A.
and
Edwards, Frances A.
2015.
First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.
Brain,
Vol. 138,
Issue. 7,
p.
1992.
Weiner, Michael W.
Veitch, Dallas P.
Aisen, Paul S.
Beckett, Laurel A.
Cairns, Nigel J.
Cedarbaum, Jesse
Green, Robert C.
Harvey, Danielle
Jack, Clifford R.
Jagust, William
Luthman, Johan
Morris, John C.
Petersen, Ronald C.
Saykin, Andrew J.
Shaw, Leslie
Shen, Li
Schwarz, Adam
Toga, Arthur W.
and
Trojanowski, John Q.
2015.
2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
Alzheimer's & Dementia,
Vol. 11,
Issue. 6,
Liu, Celina S.
Chau, Sarah A.
Ruthirakuhan, Myuri
Lanctôt, Krista L.
and
Herrmann, Nathan
2015.
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease.
CNS Drugs,
Vol. 29,
Issue. 8,
p.
615.
You, S. Christine
Walsh, Christine M.
Chiodo, Louis A.
Ketelle, Robin
Miller, Bruce L.
and
Kramer, Joel H.
2015.
Neuropsychiatric Symptoms Predict Functional Status in Alzheimer’s Disease.
Journal of Alzheimer's Disease,
Vol. 48,
Issue. 3,
p.
863.
Lin, Qiao
Cao, Yunpeng
and
Gao, Jie
2015.
The impacts of a GO-game (Chinese chess) intervention on Alzheimer disease in a Northeast Chinese population.
Frontiers in Aging Neuroscience,
Vol. 7,
Issue. ,
Xing, Yi
Tang, Yi
and
Jia, Jianping
2015.
Sex Differences in Neuropsychiatric Symptoms of Alzheimer’s Disease: The Modifying Effect of Apolipoprotein Eε4 Status.
Behavioural Neurology,
Vol. 2015,
Issue. ,
p.
1.
Bensamoun, David
Guignard, Renaud
Furst, Ansgar J.
Derreumaux, Alexandre
Manera, Valeria
Darcourt, Jacques
Benoit, Michel
Robert, Philippe H.
and
David, Renaud
2015.
Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People.
Journal of Alzheimer's Disease,
Vol. 49,
Issue. 2,
p.
387.
Mah, Linda
Szabuniewicz, Claudia
and
Fiocco, Alexandra J.
2016.
Can anxiety damage the brain?.
Current Opinion in Psychiatry,
Vol. 29,
Issue. 1,
p.
56.
Huang, Huang
Nie, Sipei
Cao, Min
Marshall, Charles
Gao, Junying
Xiao, Na
Hu, Gang
and
Xiao, Ming
2016.
Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice.
AGE,
Vol. 38,
Issue. 4,
p.
303.
Breitve, Monica H.
Hynninen, Minna J.
Brønnick, Kolbjørn
Chwiszczuk, Luiza J.
Auestad, Bjørn H.
Aarsland, Dag
and
Rongve, Arvid
2016.
A longitudinal study of anxiety and cognitive decline in dementia with Lewy bodies and Alzheimer’s disease.
Alzheimer's Research & Therapy,
Vol. 8,
Issue. 1,
Babulal, Ganesh M.
Ghoshal, Nupur
Head, Denise
Vernon, Elizabeth K.
Holtzman, David M.
Benzinger, Tammie L.S.
Fagan, Anne M.
Morris, John C.
and
Roe, Catherine M.
2016.
Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels.
The American Journal of Geriatric Psychiatry,
Vol. 24,
Issue. 11,
p.
1095.
Brown, Eric E.
Iwata, Yusuke
Chung, Jun Ku
Gerretsen, Philip
Graff-Guerrero, Ariel
and
Motoi, Yumiko
2016.
Tau in Late-Life Depression: A Systematic Review and Meta-Analysis.
Journal of Alzheimer's Disease,
Vol. 54,
Issue. 2,
p.
615.
de Oliveira, Juliana Sorraila
Abdalla, Fátima Husein
Dornelles, Guilherme Lopes
Adefegha, Stephen Adeniyi
Palma, Taís Vidal
Signor, Cristiane
da Silva Bernardi, Jamile
Baldissarelli, Jucimara
Lenz, Luana Suéling
Magni, Luana Pereira
Rubin, Maribel Antonello
Pillat, Micheli Mainardi
and
de Andrade, Cinthia Melazzo
2016.
Berberine protects against memory impairment and anxiogenic-like behavior in rats submitted to sporadic Alzheimer’s-like dementia: Involvement of acetylcholinesterase and cell death.
NeuroToxicology,
Vol. 57,
Issue. ,
p.
241.
Perna, Giampaolo
Iannone, Giuseppe
Alciati, Alessandra
and
Caldirola, Daniela
2016.
Are Anxiety Disorders Associated with Accelerated Aging? A Focus on Neuroprogression.
Neural Plasticity,
Vol. 2016,
Issue. ,
p.
1.
Zhou, L
Ma, S L
Yeung, P K K
Wong, Y H
Tsim, K W K
So, K F
Lam, L C W
and
Chung, S K
2016.
Anxiety and depression with neurogenesis defects in exchange protein directly activated by cAMP 2-deficient mice are ameliorated by a selective serotonin reuptake inhibitor, Prozac.
Translational Psychiatry,
Vol. 6,
Issue. 9,
p.
e881.